Bloomberg Markets & Finance via Youtube

Nov.18 — Pfizer and partner BioNTech SE say their Covid-19 vaccine was 95% effective in clinical trials. They will now apply for emergency use authorization in the U.S. BioNTech SE’s Chief Executive Officer Ugur Sahin appears on “Bloomberg Markets.”

READ ALSO  SE: Vaccine Stimulus Is Very Different From Fiscal Stimulus: Purves